>
Encompass Health logo

HSOA - Encompass Health Share Price

ā‚¬72.5 0.5  0.7%

Last Trade - 14/05/21

Sector
Healthcare
Size
Large Cap
Market Cap Ā£6.10bn
Enterprise Value Ā£8.58bn
Revenue Ā£3.33bn
Position in Universe 152nd / 1053
Bullish
Bearish
Unlock HSOA Revenue
Momentum
Relative Strength (%)
1m +7.68%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -0.68%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
3,116 3,646 3,914 4,277 4,605 4,644 5,133 5,544 +8.3%
-8.6 +19.8 +11.5 +18.2 +8.3 -18.4 +38.6 +6.90
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 March 2021, EncompassHealth Corp revenues increased 4% to $1.23B. Net incomeapplicable to common stockholders excluding extraordinaryitems increased 23% to $106.8M. Revenues reflect Inpatientand Other Clinical Services segment increase of 6% to$959.9M. Net income benefited from Other (income) expenseincrease from $1.9M (expense) to $1.4M (income). Dividendper share remained flat at $0.28.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for HSOA
Graphical History

Revenue

HSOA Revenue Unlock HSOA Revenue

Net Income

HSOA Net Income Unlock HSOA Revenue

Normalised EPS

HSOA Normalised EPS Unlock HSOA Revenue

PE Ratio Range

HSOA PE Ratio Range Unlock HSOA Revenue

Dividend Yield Range

HSOA Dividend Yield Range Unlock HSOA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
HSOA EPS Forecasts Unlock HSOA Revenue
Profile Summary

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 36 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice. It is an owner and operator of inpatient rehabilitation hospitals. It provides specialized rehabilitative treatment on both an inpatient and outpatient basis. It offers its home health and hospice services through Encompass Home Health and Hospice business (Encompass). Encompass operates home health and hospice agencies in 30 states, with concentrations in the Southeast, Oklahoma, and Texas. As of December 31, 2018, the Company operated 130 inpatient rehabilitation hospitals.

Directors
Last Annual December 31st, 2020
Last Interim March 31st, 2021
Incorporated February 22, 1984
Public Since September 24, 1986
No. of Shareholders: 7,214
No. of Employees: 43,000
Sector Healthcare
Industry Healthcare Providers & Services
Index
Exchange Frankfurt Stock Exchange
Shares in Issue 99,551,380
Free Float (0.0%)
Eligible for
ISAs
SIPPs
HSOA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for HSOA
Upcoming Events for HSOA
Frequently Asked Questions for Encompass Health
What is the Encompass Health share price?

As of 14/05/21, shares in Encompass Health are trading at ā‚¬72.5, giving the company a market capitalisation of Ā£6.10bn. This share price information is delayed by 15 minutes.

How has the Encompass Health share price performed this year?

Shares in Encompass Health are currently trading at ā‚¬72.5 and the price has moved by 27.19% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Encompass Health price has moved by -3.06% over the past year.

What are the analyst and broker recommendations for Encompass Health?

There are no analysts currently covering Encompass Health.

When will Encompass Health next release its financial results?

Encompass Health is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the Encompass Health dividend yield?

The Encompass Health dividend yield is 1.27% based on the trailing twelve month period.

Does Encompass Health pay a dividend?

Last year, Encompass Health paid a total dividend of 1.12, and it currently has a trailing dividend yield of 1.27%. Looking ahead, shares in Encompass Health are due to go ex-dividend on 2021-06-30 and the next dividend pay date is 2021-07-15.

When does Encompass Health next pay dividends?

Encompass Health are due to go ex-dividend on 2021-06-30 and the next dividend pay date is 2021-07-15. The historic dividend yield on Encompass Health shares is currently 1.27%.

How do I buy Encompass Health shares?

To buy shares in Encompass Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopediaā€™s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Encompass Health?

Shares in Encompass Health are currently trading at ā‚¬72.5, giving the company a market capitalisation of Ā£6.10bn.

Where are Encompass Health shares listed? Where are Encompass Health shares listed?

Here are the trading details for Encompass Health:

Country of listing: Germany
Exchange: FRA
Ticker Symbol: HSOA
What kind of share is Encompass Health?

Based on an overall assessment of its quality, value and momentum, Encompass Health is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Encompass Health share price forecast 2021?

Shares in Encompass Health are currently priced at ā‚¬72.5. At that level they are trading at 9.13% discount to the analyst consensus target price of 0.00.

Analysts covering Encompass Health currently have a consensus Earnings Per Share (EPS) forecast of 4.104 for the next financial year.

How can I tell whether the Encompass Health share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Encompass Health. Over the past six months, the relative strength of its shares against the market has been 10.8%. At the current price of ā‚¬72.5, shares in Encompass Health are trading at 14.58% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Encompass Health PE Ratio?

The Encompass Health PE ratio based on its reported earnings over the past 12 months is 27.96. The shares are currently trading at ā‚¬72.5.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Encompass Health?

Encompass Health's management team is headed by:

Leo Higdon - NEC
Mark Tarr - PRE
Yvonne Curl - IND
Donald Correll - IND
John Chidsey - IND
Edmund Fay - SVP
Andrew Price - CAO
Douglas Coltharp - CFO
April Anthony - CEX
Patrick Darby - EVP
Elissa Charbonneau - OTH
Barbara Jacobsmeyer - EVP
Anthony Hernandez - CHO
Gregory Carmichael - IND
Who are the major shareholders of Encompass Health?

Here are the top five shareholders of Encompass Health based on the size of their shareholding:

Wellington Management Company, LLP Investment Advisor/Hedge Fund
Percentage owned: 10.74% (10.7m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 9.04% (9.00m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 8.3% (8.26m shares)
William Blair Investment Management, LLC Investment Advisor/Hedge Fund
Percentage owned: 4.62% (4.60m shares)
JP Morgan Asset Management Investment Advisor
Percentage owned: 2.86% (2.85m shares)
Similar to HSOA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.